To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Researchers at the Barbara Ann Karmanos Cancer Institute have published a review article in the American Journal of Clinical Oncology on the standard of care for hormone receptor-positive, early-stage breast cancer. The study, titled “A Review of Endocrine Therapy in Early-Stage Breast Cancer: The Journey from Crudeness to Precision,” discusses how treatment models for hormone-positive breast cancer need to be more personalized. “This article summarizes the milestone trials of a new era in treating horm...
A cold February night with a slight drizzle was perfect for the fifth annual Sk8 to Elimin8 Cancer™ Detroit Celebration Ice Show at Campus Martius Park in Detroit. Many professional, local and volunteer skaters came out to perform choreographed routines and support cancer research at the Barbara Ann Karmanos Cancer Institute . ...
DBusiness Karmanos has partnered with the Michigan Department of Health and Human Services Program for Breast Cancer in Young Adults and the Gilda's of Detroit for a free, virtual and in-person Young Breast Cancer Symposium on Saturday, Jan. 14, 2023. This symposium is open to young women across the state and healthcare providers. It features breast cancer survivors who are under the age of 45. Medical oncologists Michael Simon, M.D., MPH , co-leader of the Breast Cancer Multidisciplinary Team (MDT) at ...